Toxin-Specific Antibodies for the Treatment of Clostridium difficile: Current Status and Future Perspectives

Prevention ofClostridium difficileInfection withSaccharomyces boulardii: A Systematic Review

(2016) Jennifer M Tung et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Fidaxomicin: A Macrocyclic Antibiotic for the Management of Clostridium difficile Infection

(2010) Karyn M Sullivan et al.   ANNALS OF PHARMACOTHERAPY

A bispecific nanobody to provide full protection against lethal scorpion envenoming

(2010) Issam Hmila et al.   FASEB JOURNAL

Intravenous immunoglobulin for the treatment of severeClostridium difficilecolitis: An observational study and review of the literature

(2010) Marwan S. Abougergi et al.   Journal of Hospital Medicine

Four Distinct Structural Domains in Clostridium difficile Toxin B Visualized Using SAXS

(2010) David Albesa-Jové et al.   JOURNAL OF MOLECULAR BIOLOGY

Neutralization ofClostridium difficiletoxin A using antibody combinations

(2010) Stephen J. Demarest et al.   mAbs

Anti-virulence strategies to combat bacteria-mediated disease

(2010) David A. Rasko et al.   NATURE REVIEWS DRUG DISCOVERY

Clostridium difficile— Beyond Antibiotics

(2010) Lorraine Kyne   NEW ENGLAND JOURNAL OF MEDICINE

Treatment with Monoclonal Antibodies againstClostridium difficileToxins

(2010) Israel Lowy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation

(2009) M. M. Harmsen et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom

(2009) Rahma Ben Abderrazek et al.   BIOCHEMICAL JOURNAL

Single-Domain Antibody-Nanoparticles: Promising Architectures for IncreasedStaphylococcus aureusDetection Specificity and Sensitivity

(2009) Shannon Ryan et al.   BIOCONJUGATE CHEMISTRY

Clostridium difficile: controversies and approaches to management

(2009) Martijn P Bauer et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Treatment of Clostridium difficile-Associated Disease

(2009) Daniel A. Leffler et al.   GASTROENTEROLOGY

Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain

(2009) Jennifer R. O'Connor et al.   GASTROENTEROLOGY

The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review

(2009) John O’Horo et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes

(2009) Stuart Johnson   JOURNAL OF INFECTION

The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea

(2009) Gareth C Parkes et al.   LANCET INFECTIOUS DISEASES

Single domain antibodies: promising experimental and therapeutic tools in infection and immunity

(2009) Janusz Wesolowski et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Pentabody-mediated antigen delivery induces antigen-specific mucosal immune response

(2009) Shenghua Li et al.   MOLECULAR IMMUNOLOGY

Toxin B is essential for virulence of Clostridium difficile

(2009) Dena Lyras et al.   NATURE

Clostridium difficile infection: new developments in epidemiology and pathogenesis

(2009) Maja Rupnik et al.   NATURE REVIEWS MICROBIOLOGY

A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A

(2009) David F. Gardiner et al.   VACCINE

Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs

(2009) M.M. Harmsen et al.   VACCINE

Rifamycin Antibiotics for Treatment of Clostridium difficile–Associated Diarrhea

(2008) Kevin W Garey et al.   ANNALS OF PHARMACOTHERAPY

Antibodies for the treatment of bacterial infections: current experience and future prospects

(2008) Christopher Bebbington et al.   CURRENT OPINION IN BIOTECHNOLOGY

Probiotics as prevention and treatment for diarrhea

(2008) Alfredo Guarino et al.   CURRENT OPINION IN GASTROENTEROLOGY

Active immunization of hamsters againstClostridium difficileinfection using surface-layer protein

(2008) Déirdre B. Ní Eidhin et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile

(2008) T. Dingle et al.   GLYCOBIOLOGY

Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis

(2008) N. Deckers et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Thermodynamically Stable Aggregation-Resistant Antibody Domains through Directed Evolution

(2008) Kristoffer Famm et al.   JOURNAL OF MOLECULAR BIOLOGY

Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120

(2008) A. Forsman et al.   JOURNAL OF VIROLOGY

Llama-Derived Single-Chain Antibody Fragments Directed to Rotavirus VP6 Protein Possess Broad Neutralizing Activity In Vitro and Confer Protection against Diarrhea in Mice

(2008) L. Garaicoechea et al.   JOURNAL OF VIROLOGY

VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI′

(2008) Issam Hmila et al.   MOLECULAR IMMUNOLOGY

A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial

(2008) Eero Mattila et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Structure and mode of action of clostridial glucosylating toxins: the ABCD model

(2008) Thomas Jank et al.   TRENDS IN MICROBIOLOGY